Increased Soluble CD155 in the Serum of Cancer Patients
Authors:
Open Access
- 6 April 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (4) , e0152982
Abstract
Emerging evidence suggests that DNAM-1 (CD226) play an important role in the recognition of tumor cells and their lysis by cytotoxic T lymphocytes (CTL) and NK cells. Although the DNAM-1 ligand CD155 is ubiquitously expressed in various tissues, many human tumors significantly upregulate the expression of CD155; DNAM-1 on CTL and NK cells may be involved in tumor immunity. However, unlike those in mice, human tissues also express soluble isoforms of CD155 (sCD155) that lack the transmembrane region. Here, we show that sCD155 levels were significantly higher in the sera of 262 patients with lung, gastrointestinal, breast, and gynecologic cancers than in sera from healthy donors. In addition, the sCD155 levels were significantly higher in patients with early stage (stages 1 and 2) gastric cancer than in healthy donors, and were significantly higher in patients with advanced stage (stages 3 and 4) disease than in patients in those with early stage disease and healthy donors. Moreover, the sCD155 levels were significantly decreased after surgical resection of cancers. Thus, sCD155 level in serum may be potentially useful as a biomarker for cancer development and progression.Keywords
This publication has 39 references indexed in Scilit:
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–αScience, 2010
- Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100BClinical Cancer Research, 2009
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoJournal of Clinical Investigation, 2009
- Accelerated tumor growth in mice deficient in DNAM-1 receptorJournal of Experimental Medicine, 2008
- Immune surveillance of tumorsJournal of Clinical Investigation, 2007
- Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligandsBiochemical and Biophysical Research Communications, 2005
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- CD226 Mediates Platelet and Megakaryocytic Cell Adhesion to Vascular Endothelial CellsJournal of Biological Chemistry, 2003
- Identification of secreted CD155 isoformsBiochemical and Biophysical Research Communications, 2003
- Overexpression of the CD155 gene in human colorectal carcinomaGut, 2001